Menopause Matters Forum
Menopause Discussion => All things menopause => Topic started by: Maryjane on August 29, 2017, 11:35:23 AM
-
http://www.medscape.com/viewarticle/884741
-
Thanks Maryjane. This statement in particular is encouraging
"Warning labels on low-dose vaginal estrogen preparations approved by the US Food and Drug Administration (FDA) are not based on clinical-trial evidence of vaginal estrogen "and may discourage the use of a highly effective local treatment for a common condition with adverse effects on quality of life," the authors warn. "Currently, the US FDA is considering a proposal to modify package labeling so that it better reflects the safety profile of vaginal estrogen," they add"
Taz x
-
Yes Taz that's what I thought . X
Just came up on my FB news feed , you can tell what my search engine is . 😉
-
The NICE guildelines actually state that problematic VA is likely return if local oestrogen is stopped - so I interprete that as the ok to use local oestrogen for the long term.
There info that comes with any local oestrogen should reflect the NICE guidelines. It's crazy that the leaflet is the same as for full systemic HRT.
DG x
-
I would shout and scream if my GP even hinted that I had to stop any of my medications ;). I threatened last time he was ticking boxes that I would camp on his doorstep should I have to stop ! ;)